The report "Single-cell Analysis Market by Cell Type (Human, Animal, Microbial), Product (Consumables, Instrument), Technique (Flow Cytometry, NGS, Microscopy, MS), Application (Research, Medical), End User (Pharma, Biotech, Hospitals) - Global Forecast to 2028", size is projected to reach USD 7.1 billion by 2028 from 3.5 billion in 2023, at a CAGR of 15.3% during the forecast period. Factors such as technological developments in single-cell analysis products along with increased R&D in the pharmaceutical and biotechnology sectors, growing emphasis on personalized treatment, growth in stem cell research, and the rising incidence of cancer are driving growth of single-cell analysis market. However, one of the main reasons impeding the expansion of this market is the high price of single-cell analysis equipment.
Browse 303 market data Tables and 53 Figures spread through 344 Pages and in-depth TOC on "Single-cell Analysis Market by Cell Type (Human, Animal, Microbial), Product (Consumables, Instrument), Technique (Flow Cytometry, NGS, Microscopy, MS), Application (Research, Medical), End User (Pharma, Biotech, Hospitals) - Global Forecast to 2028"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/single-cell-analysis-market-171955254.html
The consumables segment accounted for the largest share of the product segment in the single-cell analysis market in 2022.
Based on product, the single-cell analysis market is broadly segmented into consumables, and instruments. In 2022, consumables accounted for the largest share of the single-cell analysis market for product. Due to the frequent purchasing of consumables as opposed to instruments, which are considered as a one-time investment, this segment has a larger market share in the market. Consumables' numerous applications in genetic research, exosome analysis, and RNA and DNA isolation are also anticipated to fuel market expansion. Each of these applications may require specific consumables tailored to the analysis method and target molecules.
The research applications segment accounted for the largest share of the application segment in the single-cell analysis market in 2022.
Based on applications, the single-cell analysis market is categorized into two segments—medical applications and research applications. In 2022, research applications segment accounted for the largest share of single-cell analysis market. Increasing government initiatives in stem cell research and the wide usage of single-cell analysis in cancer research are the major factors driving the growth of the research applications segment.
Asia Pacific is likely to grow at double-digit growth rate during the forecast period.
The Asia Pacific region is estimated to grow at the highest CAGR in the single-cell analysis market during the forecast period. This can be attributed to the fast-growing pharmaceutical industry in this region, rising geriatric population, rising prevalence of cancer, and increasing government initiatives. Moreover, increasing chronic diseases in the countries of this region is likely to boost the market. Also, growing infectious diseases in the region is attracting several foreign investors in the market. Governments in the APAC region are supporting research in various ways, such as funding research institutes and offering tax incentives to biotech and life sciences companies. This has led to an increased demand for single-cell analysis technologies to support this research.
Some of the prominent players in the single-cell analysis market are Becton, Dickinson and Company (US), Danaher Corporation (US), Merck KGaA (Germany), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific, Inc. (US), 10x Genomics (US), Promega Corporation (US), Illumina, Inc. (US), Bio-Rad Laboratories (US), Standard BioTools (US), Agilent Technologies, Inc. (US), Tecan Group Ltd. (Switzerland), Sartorius AG (Germany), DiaSorin S.p.A. (Italy), Takara Bio, Inc. (Japan), Fluxion Biosciences (US), Menarini Silicon Biosystems Inc. (Italy), bioMérieux SA (France), Oxford Nanopore Technologies (UK), Cytek Biosciences (US), Corning Incorporated (US), Apogee Flow Systems Ltd. (UK), NanoCellect Biomedical (US), RareCyte, Inc. (US), and On-chip Biotechnologies Co., Ltd. (Japan).
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441